Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report

Overview of attention for article published in BMC Neurology, December 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs: 1 blog

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 43 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

ClinicSpeak: DMF fails to stop post-natalizumab rebound

Multiple Sclerosis Research, 20 Dec 2015

How do you switch from natalizumab to alemtuzumab? #ClinicSpeak #MSBlog #MSResearch"At Barts-MS we continue to de-risk…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.